PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.1770
https://www.valueinhealthjournal.com/article/S1098-3015(18)35072-1/fulltext
Section Title :
Section Order :
1134
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35072-1&doi=10.1016/j.jval.2018.09.1770